Illumina | ILMN - Assets


Illumina reported $6.64B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Agilent USD 12.81B 86M Dec/2025
Bio Techne USD 2.52B 3.45M Dec/2025
Bio-Rad Laboratories USD 10.58B 880.1M Dec/2025
Boston Scientific USD 43.67B 966M Dec/2025
Bruker USD 6.24B 193.5M Dec/2025
Charles River Laboratories USD 7.14B 378.39M Dec/2025
Danaher USD 83.46B 3.57B Dec/2025
Dentsply International USD 5.43B 224M Dec/2025
Edwards Lifesciences USD 13.27B 216.5M Sep/2025
Hologic USD 9.18B 165.8M Dec/2025
Illumina USD 6.64B 467M Dec/2025
Intuitive Surgical USD 20.46B 1.11B Dec/2025
IQVIA Holdings USD 29.94B 1.22B Dec/2025
Laboratory Of America USD 18.39B 131.1M Dec/2025
Mettler Toledo International USD 3.71B 191.18M Dec/2025
Myriad Genetics USD 706.6M 21.5M Dec/2025
OraSure Technologies USD 403.17M 19.93M Dec/2025
Pacific Biosciences Of California USD 784.08M 19.08M Dec/2025
Quest Diagnostics USD 16.23B 28M Dec/2025
Quidel USD 5.77B 94.2M Dec/2025
Repligen USD 2.95B 25.99M Dec/2025
Revvity USD 12.17B 29.46M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Standard Biotools USD 567.75M 28.12M Dec/2025
Thermo Fisher Scientific USD 110.34B 7.32B Dec/2025
Waters USD 5.08B 221.41M Dec/2025